rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

CG Oncology, Inc.

CGON · Nasdaq

Health CareBiotechnologyNot moving yet

CGON stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 9.8% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$49.6M
Insider sales, 12 months
$9.6M
Officials’ trades on record
0
Institutions holding
215 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$17.2M$0$47.5MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months13
Buyers · sellers1 · 2
WhoDidSharesTraded
Leonard E. PostDirectorsold500at $61.6515 Oct 2026filed 19 Oct 2026
Leonard E. PostDirectorsold500at $62.4815 Oct 2026filed 19 Oct 2026
Leonard E. PostDirectorsold1,000at $72.9815 Sep 2026filed 17 Sep 2026
Leonard E. PostDirectorsold1,000at $74.5414 Aug 2026filed 18 Aug 2026
Leonard E. PostDirectorsold1,000at $71.1715 Jul 2026filed 17 Jul 2026
James MulayDirectorsold24,165at $75.1610 Jul 2026filed 14 Jul 2026
Brian Guan-Chyun LiuDirectorbought371,085at $66.8725 Jun 2026filed 29 Jun 2026
Leonard E. PostDirectorsold5,000at $70.0024 Jun 2026filed 25 Jun 2026
Leonard E. PostDirectorsold5,000at $65.0022 Jun 2026filed 23 Jun 2026
James MulayDirectorsold654at $60.1215 Jun 2026filed 16 Jun 2026
James MulayDirectorsold1,310at $60.1215 Jun 2026filed 16 Jun 2026
Leonard E. PostDirectorsold1,000at $54.504 Jun 2026filed 5 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders215-3 on the quarter
New · exited36 · 39
Reported value$5.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
RTW INVESTMENTS, LPadded · filed 14 Aug 20268,514,590$605.0M+1,529,782+21.9%
Decheng Capital LLCunchanged · filed 14 Aug 20266,371,669$452.7M00.0%
BlackRock, Inc.added · filed 7 Aug 20266,256,288$444.5M+1,192,108+23.5%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20265,324,751$378.3M-46,481−0.9%
FMR LLCadded · filed 13 Aug 20264,161,493$295.7M+396,649+10.5%
TCG Crossover Management, LLCunchanged · filed 14 Aug 20263,670,206$260.8M00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20263,465,197$246.2M+370,099+12.0%
STATE STREET CORPadded · filed 7 Aug 20263,437,590$244.2M+790,536+29.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,316,793$235.7M+283,168+9.3%
Foresite Capital Management VI LLCadded · filed 14 Aug 20262,369,574$168.4M+148,100+6.7%
31 Mar 2024 – 30 Jun 2026
92153213Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Isabel Kalofonos Company insiderChief Commercial Officer · last 15 Oct 20260 · 0
Leonard E. Post Company insiderDirector · last 15 Oct 20260 · 20
James Mulay Company insiderDirector · last 10 Jul 20260 · 10
Brian Guan-Chyun Liu Company insiderDirector · last 25 Jun 20262 · 0
Christina Rossi Company insiderDirector · last 4 Jun 20260 · 0
Susan E. Graf Company insiderDirector · last 4 Jun 20260 · 0
Victor Edward Tong Jr. Company insiderDirector · last 4 Jun 20260 · 0
Ambaw Bellete Company insiderPresident and COO · last 15 Apr 20260 · 0
Arthur Kuan Company insiderChief Executive Officer · last 15 Apr 20260 · 0
James M. Detore Company insiderChief Financial Officer · last 15 Apr 20260 · 0
Joshua F. Patterson Company insiderOfficer · last 15 Apr 20260 · 0
Vijay Kasturi Company insiderChief Medical Officer · last 15 Apr 20261 · 0

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-25.1%
Debt to equityFY 2025 · to 31 Dec 20250.00×
Share count trendFY 2025 · to 25 Feb 20264.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$32.5M
Free cash flowFY 2025 · to 31 Dec 2025−$132.5M

Analyst forecasts

No analyst forecasts yet.